Coloplast A/S Stock Forecast for 2023 - 2025 - 2030
Updated on 06/09/2023
Coloplast A/S Stock Forecast and Price Target
Coloplast A/S's most recent price target of kr1030.00 for 2023 was provided by twelve renowned analysts over the past few months, with an average prediction of kr1030.00. If this prediction is correct, Coloplast A/S's stock could rise by 21.43 percent from its current trading price. The potential increase for the stock is kr1030.00 per share, with a possible range of kr850.00 to kr1388.00. If you want to invest in COLO B stock, you might also want to take a look at how its competitors are doing.
21.43% Upside
Coloplast A/S Fair Value Forecast for 2023 - 2025 - 2030
Coloplast A/S's Price has grown In the last two years, rising from kr794.63 to kr945.15 – a growth of 18.94%. The next year, 0 experts forecast that Coloplast A/S's Fair Value will decrease by 10.58%, reaching kr845.12. In 2030, professionals predict that Coloplast A/S's Fair Value will decrease by 9.75%, reaching kr852.99.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb Co | Outperform |
2
|
$65.30 | $80.99 | 27.11% |
| MMM Stock Forecast | 3M Co | Hold |
16
|
$100.75 | $147.79 | 18.61% |
| BEI Stock Forecast | Beiersdorf | Outperform |
17
|
117.75€ | 110.36€ | -2.34% |
| SN. Stock Forecast | Smith & Nephew | Outperform |
18
|
£11.60 | £15.98 | 39.22% |
| CTEC Stock Forecast | ConvaTec Group Plc | Outperform |
16
|
£203.00 | £0.00 | -98.45% |
Coloplast A/S Revenue Forecast for 2023 - 2025 - 2030
Coloplast A/S's Revenue has grown In the last two years, rising from kr17.94B to kr19.43B – a growth of 8.29%. The next year, 0 experts forecast that Coloplast A/S's Revenue will decrease by 4.11%, reaching kr18.63B. In 2030, professionals predict that Coloplast A/S's Revenue will decrease by 3.88%, reaching kr18.67B.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$40.95 | $71.75 | 46.52% |
| CLGN Stock Forecast | CollPlant Biotechnologies | Outperform |
7
|
$16.88 | $0.00 | 9.12% |
| 540468 Stock Forecast | KMS Medisurgi | - |
0
|
34.35 | 0.00 | 236.97% |
Coloplast A/S Dividend per Share Forecast for 2023 - 2025 - 2030
Coloplast A/S's Dividend per Share has seen impressive growth In the last two years, rising from kr12.00 to kr19.00 – a growth of 58.33%. According to the 0 analysts polled, in the next year, Coloplast A/S's Dividend per Share will fall by 14.62%, reaching kr16.22. By 2030, professionals believe that Coloplast A/S's Dividend per Share will have decreased by 12.76%, falling to kr16.58.
Coloplast A/S Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last two years, Coloplast A/S's Free Cash Flow has grown, moving from kr3.74B to kr4.37B – an increase of 16.87%. According to 0 prominent analysts, Coloplast A/S's Free Cash Flow will fall by 8.46% in the next year, reaching kr4.00B. By 2030, professionals believe that Coloplast A/S's Free Cash Flow will decrease by 7.83%, reaching kr4.03B – a concerning trend for the company.
Coloplast A/S Net Income Forecast for 2023 - 2025 - 2030
In the last two years, Coloplast A/S's Net Income has grown by 24.58%, rising from kr3.87B to kr4.83B. For the next year, 0 analysts project Coloplast A/S's Net Income to drop by 11.25%, reaching kr4.28B. By 2030, professionals believe that Coloplast A/S's Net Income will decrease by 10.24%, reaching kr4.33B – a concerning trend for the company.
Coloplast A/S EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Coloplast A/S's EBITDA has seen an increase, rising from kr6.19B to kr6.88B. This represents a growth of 11.03%. In the following year, 0 experts forecast Coloplast A/S's EBITDA will decrease by 5.46%, to kr6.50B. In 2030, professionals predict that Coloplast A/S's EBITDA will decrease by 5.11%, to kr6.53B.
Coloplast A/S EBIT Forecast for 2023 - 2025 - 2030
Coloplast A/S's EBIT has seen growth In the last two years, going from kr5.58B to kr6.34B – a gain of 13.65% According to 0 major analysts, Coloplast A/S's EBIT will fall by 6.70% in the next year, reaching kr5.91B. Professionals believe that By 2030, Coloplast A/S's EBIT will fall to kr5.94B– a 6.23% decrease from its current value.
Coloplast A/S EPS Price Prediction Forecast for 2023 - 2025 - 2030
Coloplast A/S's EPS has grown In the last two years, rising from kr19.64 to kr23.36 – a growth of 18.94%. The next year, 0 experts forecast that Coloplast A/S's EPS will decrease by 10.58%, reaching kr20.89. In 2030, professionals predict that Coloplast A/S's EPS will decrease by 9.75%, reaching kr21.08.